lung
injuri
occur
frequent
follow
hsct
significantli
contribut
morbid
mortal
immedi
post
transplant
period
month
year
follow
observ
recipi
cook
yanik
histor
approxim
half
pulmonari
complic
seen
hsct
secondari
infect
judici
use
broadspectrum
antimicrobi
agent
tip
balanc
toward
noninfecti
caus
noninfecti
lung
injuri
follow
hsct
may
mediat
either
immun
nonimmun
mechan
could
repres
noninfecti
mortal
allohsct
complic
classifi
american
thorac
societi
accord
tissu
primarili
injur
etiolog
panoskaltsismortari
et
al
tabl
diagnost
yield
could
high
sixti
percent
diagnosi
achiev
noninvas
techniqu
fobbal
permit
etiolog
diagnosi
case
suspect
ip
bal
studi
may
detect
pathogen
case
pathogen
detect
earli
fob
day
offer
better
yield
late
fob
risk
complic
fob
despit
includ
classif
pulmonari
complic
hsct
pulmonari
edema
pe
consequ
fluid
overload
fo
extrem
frequent
et
al
widespread
alveolar
injuri
absenc
activ
lower
respiratori
tract
infect
cardiac
renal
dysfunct
iatrogen
fluid
overload
clark
et
al
panoskaltsismortari
et
al
character
develop
around
day
hsct
fever
nonproduct
cough
dyspnea
tachypnea
hypoxemia
rale
diffus
alveolar
interstiti
infiltr
xray
ct
scan
follow
must
present
accept
ip
diagnosi
pathogenesi
time
incid
clinic
manifest
diagnosi
radiolog
bo
shown
tabl
treatment
prognosi
bo
includ
tabl
lung
injuri
occur
frequent
follow
hsct
significantli
contribut
morbid
mortal
immedi
post
transplant
period
month
year
follow
observ
recipientsnoninfecti
lung
injuri
follow
hsct
may
mediat
either
immun
nonimmun
mechan
could
repres
noninfecti
mortal
allohsctmost
relev
noninfecti
earli
pulmonari
complic
pulmonari
edema
fluid
overflow
idiopath
pneumonia
syndrom
diffus
alveolar
hemorrhag
vascular
endotheli
syndrometh
relev
lateonset
noninfecti
pulmonari
complic
bronchiol
obliteran
cryptogenet
organ
pneumoniaal
specif
diagnost
criteria
manag
treatment
prognosi
